<DOC>
	<DOC>NCT01212406</DOC>
	<brief_summary>Vitamin D deficiency occurs in around 50% of our transplant population. Preventive treatment with Vitamin D (D-cure) can reduce the prevalence of Bronchiolitis Obliterans Syndrome after lung transplantation</brief_summary>
	<brief_title>Vitamin D in Bronchiolitis Obliterans Syndrome</brief_title>
	<detailed_description>- Prospective, interventional, randomized, double-blind, placebo-controlled trial. - Clinical setting (tertiary University Hospital). - Investigator-driven, no pharmaceutical sponsor. - Lung transplant recipients. - Add-on of study-drug (placebo or vitamin D) to 'standard of care' (standardized, routine immunosuppressive and infectious prophylactic protocol). - 1:1 inclusion ratio (placebo:Vitamin D). - Randomisation at discharge after informed consent.</detailed_description>
	<mesh_term>Bronchiolitis</mesh_term>
	<mesh_term>Bronchiolitis Obliterans</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>Stable LTx recipients at discharge after transplantation. Signed informed consent Adult (age at least 18 years old at moment of transplantation) Able to take oral medication Prolonged and/or complicated Intensive care unitcourse after transplantation. Early (&lt;30 days posttransplant) postoperative death Major suture problems (airway stenosis or stent) Retransplantation (lung) Previous transplantation (solid organ) Multiorgan transplantation (lung+ other solid organ)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Organ rejection</keyword>
	<keyword>Lung transplantation</keyword>
	<keyword>Bronchiolitis Obliterans</keyword>
	<keyword>Vitamin D</keyword>
	<keyword>Prevention</keyword>
</DOC>